Erik Schadde to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Erik Schadde has written about Xenograft Model Antitumor Assays.
Connection Strength
0.192
-
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. Cancer Discov. 2021 10; 11(10):2544-2563.
Score: 0.192